|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 275, Issue 41, 32310-32316, October 13, 2000
From the
Received for publication, July 6, 2000
In Saccharomyces cerevisiae, copper
ions regulate gene expression through the two transcriptional
activators, Ace1 and Mac1. Ace1 mediates copper-induced gene
expression in cells exposed to stressful levels of copper salts,
whereas Mac1 activates a subset of genes under copper-deficient
conditions. DNA microarray hybridization experiments revealed a limited
set of yeast genes differentially expressed under growth conditions of
excess copper or copper deficiency. Mac1 activates the expression of
six S. cerevisiae genes, including CTR1,
CTR3, FRE1, FRE7, YFR055w, and YJL217w. Two of the last three newly identified Mac1 target genes have
no known function; the third, YFR055w, is homologous to cystathionine Copper ions are required for at least three key enzymes in the
yeast Saccharomyces cerevisiae. The ability of cells to grow on nonfermentable carbon sources is dependent on having an active cytochrome oxidase complex, which requires copper ions as cofactors. Oxidative growth requires defense molecules against reactive oxygen intermediates. Superoxide dismutase is a copper-metalloenzyme that
functions to disproportionate superoxide anions. A third, key
copper-metalloenzyme is Fet3, which is a ferro-oxidase critical for
uptake of Fe(II) (1). A myriad of other oxidases and oxygenases require
Cu(II) as a functional cofactor in other species, so additional copper-metalloenzymes may exist in S. cerevisiae.
S. cerevisiae possesses mechanisms to maintain cellular
copper levels at adequate but not excessive cellular copper levels. Copper ion homeostasis in yeast is maintained, in part, through copper-regulated expression of genes involved in copper ion uptake and
Cu(I) sequestration. Positive and negative copper ion regulation of
gene expression is observed, and both effects occur at the level of
transcription (2). Distinct mechanisms mediate activation and
inhibition of transcription in response to copper.
Conditions of copper deficiency result in the derepression of a family
of genes whose products are involved in cellular uptake of copper ions
(3-6). Two of these genes encode high affinity plasma membrane copper
ion permeases, Ctr1 and Ctr3 (5, 7). A third gene encodes the Fre1
metalloreductase, which mobilizes copper ions from oxidized copper
complexes (4, 8, 9). The expression of these genes is a cellular
response to inadequate intracellular copper levels. In copper-replete
cells, expression of CTR1, CTR3, and
FRE1 is inhibited (3-5), but copper ion uptake can still
occur through low affinity transporters, such as Ctr2, Fet4, and Smf1
(10-12).
The expression of high affinity copper uptake genes is regulated at the
level of transcription through the Mac1 transcriptional activator (13).
Mac1 is a functional transcriptional activator in copper-deficient
cells but is inhibited in copper-replete cells by a copper-induced,
intramolecular interaction that represses both DNA binding and
transactivation activities (14-16). MAC1 was originally
identified as a partially dominant mutation, designated MAC1up1 (13). Cells harboring the
MAC1up1 allele were found to be incapable of
repression of copper-uptake genes (4, 6). As a result of constitutive
expression of the transporters, MAC1up1 cells
are hypersensitive to elevated levels of copper salts in the growth
medium (13). In contrast, cells lacking a functional Mac1 show reduced
copper transport and exhibit copper-deficient phenotypes (13). Mac1
binds to duplicated TTTGCTCA promoter sequences in CTR1,
CTR3, FRE1, and the FRE1 homolog
FRE7 (5, 6, 17, 18). Two repeats of this element are
necessary for in vivo activity, although neither the
orientation nor spacing between repeats appears critical (5, 6,
17).
A different subset of genes is transcriptionally activated when the
extracellular copper concentration exceeds 1 µM. This is
a protective response to counteract the cytotoxicity of copper ions.
The copper-activated genes include CUP1, CRS5,
and SOD1 (19-21). CUP1 and CRS5
encode cysteinyl-rich polypeptides in the metallothionein family (19,
22). CUP1 is the dominant locus that confers the ability of
yeast cells to propagate in medium containing copper salts (22-24).
Cells highly resistant to copper salts contain a CUP1 locus
with tandem arrays of genes encoding the Cup1 metallothionein (23). In
addition to its role in dismuting superoxide anions, Sod1 has a
secondary role of contributing to copper buffering in S. cerevisiae (25).
Cu(I) activation of CUP1 expression is mediated by Ace1 in
S. cerevisiae (26, 27). Cu(I) ion binding within the
copper-regulatory domain of Ace1 stabilizes a specific tertiary fold
capable of high affinity interaction with specific DNA promoter
sequences. Cu(I) triggering involves formation of a tetracopper
thiolate cluster within the regulatory domain (28). CUP1,
CRS5, and SOD1 contain CuAce1 binding sites
within 5' promoter sequences (20, 29).
Thus, the known genes regulated by Mac1 and Ace1 in S. cerevisiae are functionally important in copper homeostasis. To
identify other yeast genes that may likewise be important in copper
homeostasis, we used DNA microarray technology to evaluate differential
expression of genes in cells varying in copper ion status. DNA
microarrays containing approximately 6120 genes from S. cerevisiae printed on glass slides were used to identify genes up-
or down-regulated by activated Mac1 and Ace1.
Yeast Strains and Culture Conditions--
The yeast strains
used, CM66J (MAT RNA Isolation and Microarray Analysis--
Cells were harvested
from 300 ml of culture at an A600 nm of
0.4 or following 60 min of treatment with 100 µM BCS or 30 min of treatment with 100 µM CuSO4. Total
RNA was isolated by the hot acid phenol method. Quantitation of RNA was
carried out by UV spectroscopy. mRNA was isolated from total RNA
using the Poly(A)T tract mRNA Isolation System IV kit from Promega
following the manufacturer's instructions.
Three types of microarray experiments were conducted. First, wild-type
and MAC1up1 cells were cultured in LCCM. Second,
wild-type cells pregrown in LCCM medium to an
A600 nm of 0.4 were incubated in the presence and absence of 100 µM BCS for 30 or 60 min prior
to harvesting. Third, wild-type cells pregrown in CM medium to an
A600 nm of 0.4 were incubated in the presence
and absence of 100 µM CuSO4 for 30 min.
Cy3-dUTP or Cy5-dUTP (Amersham Pharmacia Biotech) was incorporated
during reverse transcription of the polyadenylated RNA. The
fluorescently labeled product was recovered and hybridized to
microarrays, washed, and scanned as described previously (33).
Vectors--
Plasmids Dg5-7b, generously supplied by D. Eide,
contains a 29-bp insert of the ZRE from the ZRT1 promoter
(34) in the mRNA Quantitation by S1 Nuclease Analysis--
Total RNA
isolated from mid-logarithmic cells was hybridized with a
32P-labeled, single-stranded DNA oligonucleotide and
digested with S1 nuclease. The samples were electrophoresed through a
8% polyacrylamide, 5 M urea gel, and data were quantified
by using a Bio-Rad FX Imager and Quantity one software (Bio-Rad Inc.).
S1 probes used included 57-75 nucleotides of the 5' open reading frame
sequences of candidate genes, 40 nucleotides of the calmodulin
(CDM1) 5' open reading frame, and 60 nucleotides from the
lacZ open reading frame.
Metal Ion Analysis of Cells--
Cells were harvested, washed
twice, and digested for 60 min with 200 µl nitric/perchloric acid
mixture (5:2) at 110 °C. Following digestion, the sample volume was
adjusted to 1 ml and clarified, prior to analysis, using a Perkin-Elmer
Optima 3100 XL ICP. For each element two absorption lines were used,
and readings from four independent measurements were taken, averaged,
and normalized to cell number.
Our strategy to catalog genes activated by Mac1 and Ace1 was to
use duplicated DNA microarray experiments as a screen to identify genes
consistently up-regulated under activating conditions. In each case,
candidate genes were evaluated by secondary tests to verify the
differential expression and to determine whether the induction was a
direct or indirect effect of Mac1 or Ace1 activation.
The strategy used to screen for Mac1-induced genes was 4-fold. First,
DNA microarray experiments were conducted with a yeast strain
containing a gain-of-function MAC1up1 allele
compared with its isogenic control. MAC1up1
cells are constitutively active in expressing CTR1,
CTR3, FRE1, and FRE7 (5, 13, 17). Many
laboratory strains do not express CTR3 because of a
transposon insertion (37). This DNA microarray experiment was carried
out in triplicate. The second strategy was to identify genes induced in
copper-deficient cells as Mac1 is activated under these conditions.
Efficient Mac1 activation is dependent on culturing cells in low copper
medium and adding the Cu(I)-specific chelator BCS to further lower the
available copper ion pools (5). Thus, DNA microarray experiments were carried out on cells treated with BCS for short periods of time to
focus on primary effects of copper deficiency. Third, genes differentially expressed both in MAC1up1 cells
and by the addition of BCS were tested for differential mRNA
expression by the S1 nuclease protection assay to quantify mRNA
levels. Fourth, these genes were evaluated for Mac1 DNA-binding sites
in 5' promoter sequences. The consensus Mac1 binding site is
TTTGC(T/G)C(A/G) (17). Genes with elevated expression in MAC1up1 cells and induced by the addition of BCS
as determined by both DNA microarray and S1 nuclease analyses and
containing at least one Mac1 DNA-binding site were considered
candidates for primary Mac1 induced genes. Genes up-regulated in
MAC1up1 cells but not induced by short BCS
treatment and lacking a candidate Mac1 binding site were considered
candidates for secondary responses.
Three DNA microarray experiments were conducted comparing wild-type and
MAC1up1 cells. Duplicate experiments were
conducted on mRNA isolated from exponentially growing wild-type and
MAC1up1 cells of S. cerevisiae strain
CM66J. Fluorescently labeled cDNA was prepared from mRNA
isolated from wild-type cells by reverse transcriptase in the presence
of Cy3 (green)-labeled dUTP and from MAC1up1
cells by reverse transcription in the presence of Cy5 (red)-labeled dUTP. The labeled cDNAs were mixed and hybridized to the
microarrays. The fluorescence intensities of the Cy3 and Cy5
fluorophores were quantified to provide a quantitative measure of the
relative abundance of mRNA levels in the two cell populations. A
third microarray experiment was conducted with wild-type and
MAC1up1 cells of strain BR10 grown to late log
phase. Table I shows fluorescence
ratios of genes differentially expressed in these three experiments.
The known Mac1 regulated genes (CTR1, FRE1, and
FRE7) were clearly up-regulated in each experiment. Ratios of mRNA levels of CTR1, FRE1, and
FRE7 in MAC1up1 versus
wild-type cells exhibited mean values of 4, 7, and 6, respectively.
Because strain CM66J contained a FRE1/HIS3 fusion gene,
differential expression of HIS3 from the FRE1
promoter was also observed. CTR3 was induced 8-fold in
MAC1up1 cells of strain BR10 but was not
expressed in strain CM66J. In addition to known Mac1-regulated
genes, >50 genes exhibited a moderate (>1.5-fold) induction in
MAC1up1 cells in any given experiment. However,
only five new genes were moderately induced in all three experiments.
These genes included CUP1, PHO5, and YJL217w.
CUP1 expression is likely elevated in MAC1up1 cells as expression of the high affinity
copper transport system is constitutive, resulting in elevated uptake
of copper ions (4). Metal analysis revealed that cellular copper levels
were elevated 6-fold in MAC1up1 cells compared
with wild-type cells.
To determine whether these genes were directly Mac1-induced, we carried
out microarray experiments in which wild-type cells cultured in low
copper medium were treated with the Cu(I)-specific chelator for either
30 or 60 min. These conditions are known to induce CTR1
expression (3-5). mRNA was isolated from cells cultured in the
presence and absence of BCS, and labeled cDNA was prepared as
before for DNA microarray hybridization. As expected, CTR1, FRE1, and FRE7 were up-regulated by short
treatments with BCS (Table I). In contrast, neither CUP1 nor
PHO5 were BCS-induced.
Thirty genes showed moderately elevated expression in
MAC1up1 exponentially growing cells. Only 17 of
these were also induced by BCS (60-min treatment) (Table I). Two of
these genes, YFR055w and YJL217w, showed marked enhancements in
expression in MAC1up1 cells and BCS-treated
cells (Fig. 1A). S1 analysis
was performed as an independent verification of differential expression
using the same RNA samples used to prepare mRNA for the array
experiments. Transcripts of YFR055w and YJL217w were markedly elevated
in MAC1up1 cells and by BCS treatment (60 min
BCS) (Fig. 1A). YFR055w expression was elevated 8-fold in
MAC1up1 cells and 3-fold by 60 min BCS
treatment. YJL217w expression was enhanced 6-fold in
MAC1up1 cells (same RNA as in experiment 2) and
2-fold by the 60 min BCS treatment. Maximal expression of
FRE1, FRE7, CTR1, YFR055w, and YJL217w
occurred by 60 min of treatment with BCS (data not shown). Neither
YFR055w nor YJL217w were induced by BCS in mac1-1 cells,
suggesting that copper metalloregulation of these genes is mediated by
Mac1 (Fig. 1B).
The four known Mac1-regulated genes contain at least two binding sites for Mac1 activation. However, YFR055w and YJL217w each have one perfect Mac1 consensus DNA-binding site, although additional nonconsensus sites exist that may be functional. Thus, YFR055w and YJL217w satisfy the criteria of being direct target genes of Mac1. A gene divergently expressed from FRE1, YLR213c, was up-regulated in MAC1up1 cells and induced by BCS in strain BR10. S1 analysis of wild-type BR10 cells treated with 100 µM BCS for 60 min resulted in a 15-fold induction in FRE1 and a weaker 4-fold induction of YLR213c. In contrast, expression of YLR213c in strain CM66J was very low under all conditions. A number of genes in the PHO regulon (PHO5, PHO11, PHO12, and PHO84) were up-regulated in MAC1up1 cells but not induced by BCS treatment. PHO5 expression was enhanced 7- and 4-fold in MAC1up1 cells in two array experiments but unaffected by BCS treatment. Evaluation of PHO5 mRNA levels by S1 analysis confirmed the induction in MAC1up1 cells (13-fold enhancement) and failed to show any induction by BCS treatment. The lack of induction by BCS suggested that PHO5 induction may be a secondary effect of phosphate depletion in MAC1up1 cells. PHO5 expression is regulated by the Pho4 transcription factor through, in part, cellular phosphate levels. MAC1up1 cells containing a pho4 mutation failed to show a Mac1up1-dependent enhanced expression of PHO5, consistent with the postulate that elevation of the PHO regulon arises from selective depletion of the cellular phosphate pool in MAC1up1 cells (data not shown). Additional studies were carried out on the remaining marginal candidates listed in Table I. A yeast DNA microarray experiment was repeated at the University of Utah microarray facility comparing wild-type cells to MAC1up1 cells. None of the marginal candidates were up-regulated in this experiment. Secondly, most of these genes lacked a consensus Mac1 binding site in 5' DNA sequences. Those containing a candidate Mac1 binding site were tested by S1 analysis. Quantitation of transcripts of YBR105c, YHR088w, and YKL082c revealed no enhancement in MAC1up1 cells and no induction by BCS. DNA microarrays were also used to screen for genes with diminished
expression in MAC1up1 cells. Two genes,
ZRT1 and ZRT2, encoding zinc plasma membrane transporters, were markedly repressed in MAC1up1
cells. S1 analysis confirmed that ZRT1 is markedly inhibited (25-fold) in MAC1up1 cells, and ZRT2
was down 2-fold (Fig. 2A). In
addition to ZRT1 and ZRT2, five other genes were
slightly down-regulated in MAC1up1 cells as well
as in BCS-treated cells by microarray experiments. However, S1 analysis
did not corroborate the down-regulation (data not shown).
Because ZRT1 and ZRT2 are transcriptionally
activated by the Zap1 transcription factor in zinc-deficient cells, the
down-regulation of ZRT1 may arise from enhanced zinc uptake
in MAC1up1 cells and zinc inhibition of Zap1.
Alternatively, ZRT1 may be repressed by a direct effect of
Mac1. The sequence upstream of ZRT1 contains a candidate
Mac1 binding site. To determine whether the Mac1up1 effect
was primary or secondary, the zinc-responsive promoter element (ZRE)
from ZRT1 was cloned into a UAS-less vector (pNB404) with
lacZ as the reporter gene. ZRT1 and
ZRE/lacZ expression were both markedly diminished in
MAC1up1 cells relative to wild-type cells,
whereas CTR1 showed the expected elevated expression in
Mac1up1 cells (Fig. 2B). However,
ZRT1 and ZRE/lacZ expression was unaffected in
wild-type cells treated with BCS for 60 or 90 min, suggesting that the
down-regulation was not a direct effect of Mac1. Furthermore, no
enhanced ZRT1 expression was observed in mac1 The copper-activated CUP1 gene is induced within 30 min of the addition of 100 µM CuSO4 to yeast cells. Elevated copper levels are known to induce expression of CUP1, CRS5, and SOD1 through the copper-activated Ace1 transcription factor. To determine whether other genes are modulated by elevated copper in the growth medium, mRNA samples from wild-type cells growing exponentially in the presence or absence of a 30-min exposure to 100 µM CuSO4 were compared by differential hybridization to DNA microarrays. The experiment was carried out with two different pairs of cultures. CUP1 was enhanced 8- and 4.5-fold in cells treated with 100 µM Cu(II) (Table II). In contrast, CRS5 was elevated 1.8- and 2.6-fold in the two experiments. Curiously, SOD1 expression was elevated in only one of the two experiments. In addition to the known targets of Ace1, only two other genes, FET3 and FTR1, showed elevated expression (>1.5-fold) in copper-treated cells (Table II). These two genes encode proteins involved in the high affinity iron uptake system of yeast. FET3 expression was elevated 5- and 3-fold in the two experiments, whereas FTR1 was elevated 5- and 2-fold. S1 analysis of the same RNA used in the microarray experiments confirmed the copper-induced expression of FET3 and FTR1 (Fig. 3A).
FET3 and FTR1 are known to be highly expressed in
iron-deficient yeast cells (36)). Expression of these genes is induced in iron-deficient cells by the Aft1 transcriptional activator (36). At
least three models may explain the copper induction of FET3.
These include: 1) copper-induced diminution in cellular iron pools,
activating Aft1, 2) direct activation of FET3 expression by
CuAce1, and 3) copper-dependent loss of potential
repression activity of Mac1. To determine whether FET3
induction was dependent on Aft1, we investigated whether copper
induction of FET3 was related to the iron status of cells.
Copper-induced expression of FET3 was observed in
iron-replete cells, but not Fe-deficient cells, in which
FET3 expression was fully derepressed (Fig. 3B). Furthermore, no copper-stimulated FET3 and FTR1
expression was observed in aft1 Both FET3 and FTR1 contain candidate Ace1
DNA-binding sites in their 5' sequences, suggesting that the observed
copper induction may in part be mediated by Ace1. Consistent with this
postulate, copper induction of FET3 and CUP1 was
abrogated in ace1
The third candidate mechanism involves copper inhibition of Mac1 function. Mac1 was recently reported to be an active repressor of FET3 in S. cerevisiae (38). Copper-induced expression of FET3 may therefore arise from the known copper-inactivation of Mac1 function. This clearly is not the mechanism of copper-induced expression of FET3 and FTR1 for two reasons. First, no reproducible diminution in FET3 was observed in the various MAC1up1 array experiments or S1 analyses of MAC1up1 cells. Second, the reported derepression of FET3 levels in mac1 null cells was not reproduced in two distinct strains of S. cerevisiae, including the strain used in the published experiment. Expression of a limited number of other genes was inhibited in cells
treated with 100 µM Cu(II) for 30 min. Genes activated by
Mac1 were, as expected, inhibited in their expression by added copper.
Both newly identified Mac1-regulated genes (YFR055w and YJL217w) were
inhibited in their expression in copper-treated cells (data not shown).
DNA microarray hybridization experiments identified a specific set of yeast genes differentially expressed under growth conditions of copper deficiency or copper excess. Two transcription factors, Mac1 and Ace1, were previously shown to mediate transcriptional regulation of S. cerevisiae genes by copper. In addition to the known targets of Mac1 and Ace1, a limited number of new genes were identified. A single DNA microarray experiment has the potential to reveal candidate genes differentially expressed under two different conditions. However, a more systematic strategy, using DNA microarrays to compare multiple related conditions, combined with secondary tests successfully restricted the candidate list to a common set of genes. Mac1 mediates activation of genes under conditions of copper
deficiency. Of the four known targets of Mac1, FRE1,
FRE7, CTR1, and CTR3, three encode
proteins important in high affinity uptake of copper ions. Thus, the
genomic screens have the potential of identifying other genes whose
products are important in copper homeostasis. Two new Mac1 regulated
genes are YFR055w and YJL217w. The clearest evidence that these genes
are Mac1-regulated is that they are induced by the copper chelator BCS
in a wild-type strain but not in a mac1 YFR055w and YJL217w each have one perfect Mac1 consensus binding site in their 5'-flanking sequences. The four known Mac1-regulated genes require two binding sites for Mac1 activation. Although YFR055w and YJL217w contain only one consensus site, additional nonconsensus sites exist that may be functional. A third candidate Mac1-regulated gene, YLR213c, is adjacent to, and transcribed divergently from FRE1. A 644-bp interval separates the two open reading frames. Two direct repeats of the Mac1 binding site are found halfway between the two open reading frames. These promoter elements may therefore mediate copper regulation of expression of both divergent genes. The significance of this response is uncertain, however, because YLR213c was markedly induced by copper deficiency in only one of the two strains used in the present studies. Although a number of genes were observed to be slightly induced in Mac1up1 cells and in response to BCS treatment, we consider it unlikely that any of these are directly activated by Mac1, because their induction could not be confirmed by S1 analysis. Thus, the Mac1 regulon appears to consist of only seven genes activated under copper-deficient conditions. A number of genes differentially expressed in MAC1up1 cells appear not to be direct targets of Mac1. Induction or repression of these genes is likely a secondary effect of physiological changes in cells containing a constitutively active Mac1. Genes up-regulated in MAC1up1 cells include CUP1, PHO regulon genes, and a candidate hexose transporter HXT17. CUP1 expression is likely enhanced by virtue of constitutive expression of the high affinity copper transport system. Elevated copper transport will stimulate CUP1 expression through copper activation of Ace1. The PHO regulon is derepressed presumably by virtue of phosphate deprivation in MAC1up1 cells. The apparent phosphate deprivation occurring in MAC1up1 cells is not obviously explained based on the function of known Mac1-regulated genes. Microarray experiments are useful for evaluating changes in cellular physiology. Genes down-regulated in MAC1up1 cells include ZRT1 and ZRT2. These two zinc transporter genes are down-regulated in zinc-replete cells, suggesting that MAC1up1 cells may either preferentially accumulate Zn(II) or contain an elevated nonsequestered Zn(II) pool. Ace1 mediates induction of gene expression under growth conditions of excess copper. The three known targets of Ace1 include the two metallothionein genes CUP1 and CRS5 and the SOD1 superoxide dismutase. The unexpected result was the copper-induced activation of FET3 and FTR1. Fet3 and Ftr1 function in high affinity iron uptake and are induced in iron-deficient cells through the Aft1 transcriptional activator (40). Three lines of evidence suggest that the rapid copper-induced
expression of FET3 arises from a transient diminution in a
cellular iron pool resulting in Aft1 activation. First, copper
induction of FET3 was abrogated in an aft1 Several interconnections between copper and iron metabolism are known. Copper is important for iron uptake through its role as a cofactor in the Fet3 trinuclear copper oxidase. Copper ions are provided for Fet3 biosynthesis by the copper-transporting, P-type ATPase Ccc2 (41). In addition, the Fre1 metalloreductase is co-regulated by copper and iron ions through Mac1 and Aft1 factors, respectively. The observation that the cellular concentrations of copper ions can be
coupled to activation and/or inhibition of gene expression in yeast
implies that similar reactions may occur in other eukaryotes. Many
examples exist of yeast being a Rosetta stone for the understanding of
animal physiological processes, so a significant question arises of how
applicable copper metalloregulation in yeast will be to animal cells.
Clearly, microarray analysis using animal DNA clones may be useful in
determining whether copper metalloregulation of transcription occurs in
animal cells.
* This work was supported by NCI, National Institutes of Health Grants CA61286 (to D. R. W.) and HG00983 (to P. O. B.) and by funds from the Howard Hughes Medical Institute. The Biotechnology Core Facility for DNA synthesis at the University of Utah is supported by National Institutes of Health Grant 5P30-CA 42014.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Associate investigator of the Howard Hughes Medical Institute.
Published, JBC Papers in Press, August 1, 2000, DOI 10.1074/jbc.M005946200
2 C. Philpott, unpublished observations.
The abbreviations used are: LCCM, low copper complete medium; BCS, bathocuproine sulfonate; bp, base pair(s).
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||